Vivian Szymczuk

Also affiliated with National Institute of Dental and Craniofacial Research

MedicineDentistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone”.

Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone

New England Journal of Medicine(2023)10.1056/nejmc2214862

N/A

1.8DataRank · unranked

67 citations

Zachary Michel, Kristen S. Pan, Jocelyn Taylor, Vivian Szymczuk, Sriram S. Paravastu +9 more

RANKL inhibition reduces lesional cellularity and Gαs variant expression and enables osteogenic maturation in fibrous dysplasia

Bone Research(2024)10.1038/s41413-023-00311-7

N/A

0.598DataRank · unranked

22 citations

Jarred M. Whitlock, Zachary Michel, Kristen S. Pan, Jocelyn Taylor, Vivian Szymczuk +9 more

RANKL inhibition with denosumab improves fibrous dysplasia by decreasing lesional cell proliferation and increasing osteogenesis

medRxiv(2022)10.1101/2022.10.24.22281375

N/A

0DataRank · unranked

4 citations

Jarred M. Whitlock, Zachary Michel, Kristen S. Pan, Jocelyn Taylor, Vivian Szymczuk +12 more

Craniofacial Fibrous Dysplasia: Clinical and Therapeutic Implications

Current Osteoporosis Reports(2023)10.1007/s11914-023-00779-6

N/A

0DataRank · unranked

34 citations

Jocelyn Taylor, Alison M. Boyce, Vivian Szymczuk

Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document

The Journal of Clinical Endocrinology & Metabolism(2023)10.1210/clinem/dgad657

N/A

0DataRank · unranked

26 citations

Vivian Szymczuk, Wolfgang Högler, Signe Sparre Beck‐Nielsen, Suma Uday, Nadia Merchant +5 more

Serum Phosphorus as a Driver of Skeletal Morbidity in Fibrous Dysplasia

The Journal of Clinical Endocrinology & Metabolism(2023)10.1210/clinem/dgad671

N/A

0DataRank · unranked

13 citations

Charles Osamor, Jocelyn Taylor, Xiaobai Li, Vivian Szymczuk, Alison M. Boyce +1 more

Lesion Expansion in Gnathic Fibrous Dysplasia: Natural History, Indicators of Progression, and Response to Bisphosphonates

Journal of Bone and Mineral Research(2023)10.1002/jbmr.4886

N/A

0DataRank · unranked

12 citations

Jocelyn Taylor, Vivian Szymczuk, Alison M Boyce, Kristen S. Pan

RANKL inhibition reduces lesional cellularity, Gαs variant expression and enables osteogenic maturation in fibrous dysplasia

Research Square(2023)10.21203/rs.3.rs-2977792/v1

N/A

0DataRank · unranked

0 citations

Jarred M. Whitlock, Zachary Michel, Kristen S. Pan, Jocelyn Taylor, Vivian Szymczuk +6 more

Burosumab treatment for fibrous dysplasia

Bone(2021)10.1016/j.bone.2021.116004

N/A

0DataRank · unranked

40 citations

Vivian Szymczuk, Bethany Auble, Alison M. Boyce, Anne Gladding

Safety and Efficacy of Moderate-dose Denosumab in Fibrous Dysplasia: Observational Results From a Phase 2 Clinical Trial

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae867

N/A

0DataRank · unranked

6 citations

Ibrahim I Elbashir, Ramzy Ahmed, Luis F de Castro, Kelly Milligan, Xiaobai Li +3 more

Endocrinopathies in Leukodystrophy

Current problems in pediatric and adolescent health care(2022)10.1016/j.cppeds.2022.101351

N/A

0DataRank · unranked

3 citations

Nadia Merchant, Vivian Szymczuk